New Home Sales and Personal Income on the Docket — Data Week Ahead Update
The following are median forecasts for this week's remaining U.S. data from a survey compiled by The Wall Street Journal.
DATE TIME RELEASE PERIOD CONSENSUS PREVIOUS Tuesday 0900 S&P/Case-Shiller Jul +6.0% (8) +6.5% 20-City HPI Y/Y 1000 Richmond Fed Mfg Svy Sep -15.5 (4) -19 1000 Consumer Confidence Sep 104.0 (23) 103.3 Wednesday 1000 New Home Sales Aug 700K (22) 739K -- percent change Aug -5.3% +10.6% Thursday 0830 Jobless Claims Sep 21 223K (18) 219K 0830 Real GDP (3rd Reading) 2Q +3.0% (22) +3.0%* 0830 GDP Prices (3rd Reading) 2Q +2.5% (7) +2.5%* 0830 Durable Goods Orders Aug -3.0% (22) +9.8%** 1000 Pending Home Sales Aug +1.0% (13) -5.5% 1100 Kansas City Fed Mfg Svy Sep -5 (3) -3 Composite Index Friday 0830 Personal Income Aug +0.4% (23) +0.3% 0830 Consumer Spending Aug +0.3% (22) +0.5% 0830 PCE Prices M/M Aug +0.1% (17) +0.2% 0830 PCE Prices Y/Y Aug +2.3% (14) +2.5% 0830 Core PCE Prices M/M Aug +0.2% (21) +0.2% 0830 Core PCE Prices Y/Y Aug +2.7% (15) +2.6% 1000 Consumer Sentiment Sep 69.3 (17) 69.0*** (Final) *2Q 2nd Reading **Revised Figure ***Sep Prelim Reading (Figures in parentheses refer to number of economists surveyed.) Write to Donna Huneke at dataweekahead@wsj.com
(END) Dow Jones Newswires
September 23, 2024 14:14 ET (18:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk